DNMT2 methyltransferase. Biochemistry 2012, 51, 4438444. Jones, P.A.; Baylin, S.B. The epigenomics of cancer. Cell 2007, 128, 68392. Berdasco, M.; Esteller, M. Aberrant epigenetic landscape in cancer: How cellular identity goes awry. Dev. Cell 2010, 19, 69811. Wild, L.; Flanagan, J.M. Genome-wide hypomethylation in cancer may perhaps be a passive consequence of transformation. Biochim. Biophys. Acta 2010, 1806, 507. Pastor, W.A.; Aravind, L.; Rao, A. TETonic shift: Biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 2013, 14, 34156.Int. J. Mol. Sci. 2013, 14 20.21. 22.23.24.25.26.27. 28. 29.30. 31.32.33.34.Hashimoto, H.; Liu, Y.; Upadhyay, A.K.; Chang, Y.; Howerton, S.B.; Vertino, P.M.; Zhang, X.; Cheng, X. Recognition and prospective mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 2012, 40, 4841849. Valinluck, V.; Sowers, L.C. Endogenous cytosine harm merchandise alter the web site selectivity of human DNA maintenance methyltransferase DNMT1.Veratramine medchemexpress Cancer Res.Velagliflozin Autophagy 2007, 67, 94650. He, Y.-F.; Li, B.-Z.; Li, Z.; Liu, P.; Wang, Y.; Tang, Q.; Ding, J.; Jia, Y.; Chen, Z.; Li, L.; et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333, 1303307. Song, C.-X.; Clark, T.A.; Lu, X.Y.; Kislyuk, A.; Dai, Q.; Turner, S.W.; He, C.; Korlach, J. Sensitive and precise single-molecule sequencing of 5-hydroxymethylcytosine. Nat. Procedures 2012, 9, 757. Sun, M.; Song, C.X.; Huang, H.; Frankenberger, C.A.; Sankarasharma, D.; Gomes, S.; Chen, P.; Chen, J.; Chada, K.K.; He, C.; et al. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc. Natl. Acad. Sci. USA 2013, 110, 9920925. Hsu, C.-H.; Peng, K.L.; Kang, M.L.; Chen, Y.R.; Yang, Y.C.; Tsai, C.H.; Chu, C.S.; Jeng, Y.M.; Chen, Y.T.; Lin, F.M.; et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2012, two, 56879. Liu, C.; Liu, L.; Chen, X.; Shen, J.; Shan, J.; Xu, Y.; Yang, Z.; Wu, L.; Xia, F.; Bie, P.; et al. Reduce of 5-Hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS 1 2013, eight, e62828. Maul, R.W.; Gearhart, P.J. Aid and somatic hypermutation. Adv. Immunol. 2010, 105, 15991. Bhutani, N.; Brady, J.J.; Damian, M.; Sacco, A.PMID:26760947 ; Corbel, S.Y.; Blau, H.M. Reprogramming towards pluripotency demands AID-dependent DNA demethylation. Nature 2010, 463, 1042047. M ivier, R.; Gallais, R.; Tiffoche, C.; Le P on, C.; Jurkowska, R.Z.; Carmouche, R.P.; Ibberson, D.; Barath, P.; Demay, F.; Reid, G.; et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452, 450. Kalari, S.; Pfeifer, G.P. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv. Genet. 2010, 70, 27708. Peng, D.F.; Kanai, Y.; Sawada, M.; Ushijima, S.; Hiraoka, N.; Kosuge, T.; Hirohashi, S. Enhanced DNA methyltransferase 1 (DNMT1) protein expression in precancerous situations and ductal carcinomas from the pancreas. Cancer Sci. 2005, 96, 40308. Belinsky, S.A.; Nikula, K.J.; Baylin, S.B.; Issa, J.P. Elevated cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA 1996, 93, 4045050. Lopatina, N.G.; Vanyushin, B.F.; Cronin, G.M.; Poirier, L.A. Elevated expression and altered pattern of activity of DNA methyltransferase in liver tumors of rats fed methyl-de.